Alexander Häge

1.4k total citations · 1 hit paper
27 papers, 348 citations indexed

About

Alexander Häge is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Alexander Häge has authored 27 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 14 papers in Clinical Psychology and 9 papers in Cognitive Neuroscience. Recurrent topics in Alexander Häge's work include Attention Deficit Hyperactivity Disorder (20 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Obsessive-Compulsive Spectrum Disorders (6 papers). Alexander Häge is often cited by papers focused on Attention Deficit Hyperactivity Disorder (20 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Obsessive-Compulsive Spectrum Disorders (6 papers). Alexander Häge collaborates with scholars based in Germany, Netherlands and United Kingdom. Alexander Häge's co-authors include Konstantin Mechler, Tobias Banaschewski, Sarah Hohmann, Regina Dittmann, Jan K. Buitelaar, David Coghill, Péter Nagy, Ben Adeyi, Steven Williams and Beatriz Caballero and has published in prestigious journals such as PLoS ONE, Psychological Medicine and Pharmacology & Therapeutics.

In The Last Decade

Alexander Häge

24 papers receiving 336 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based pharmacological treatment options for ADHD in children and adolescents

2021 146 citations Konstantin Mechler, Tobias Banaschewski et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Häge Germany	10	255	132	99	46	37	27	348
Joel Young United States	13	372 1.5×	182 1.4×	88 0.9×	46 1.0×	43 1.2×	27	435
Ernie Anand United States	6	338 1.3×	149 1.1×	96 1.0×	33 0.7×	31 0.8×	12	371
Tatiana Laufer da Silva Brazil	6	214 0.8×	90 0.7×	111 1.1×	39 0.8×	21 0.6×	7	314
Franz Joseph Freisleder Germany	9	234 0.9×	177 1.3×	122 1.2×	27 0.6×	34 0.9×	18	432
Thiago Gatti Pianca Brazil	11	201 0.8×	87 0.7×	115 1.2×	44 1.0×	18 0.5×	15	361
T. Babcock United States	12	399 1.6×	201 1.5×	165 1.7×	27 0.6×	54 1.5×	28	491
Michal Goetz Czechia	13	242 0.9×	92 0.7×	104 1.1×	15 0.3×	61 1.6×	21	347
Péter Nagy Hungary	14	379 1.5×	254 1.9×	180 1.8×	39 0.8×	69 1.9×	26	575
Martin Gignac Canada	11	411 1.6×	155 1.2×	225 2.3×	44 1.0×	27 0.7×	21	509
Ronald L. Lindsay United States	13	366 1.4×	227 1.7×	117 1.2×	75 1.6×	114 3.1×	26	529

Countries citing papers authored by Alexander Häge

Since Specialization

Citations

This map shows the geographic impact of Alexander Häge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Häge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Häge more than expected).

Fields of papers citing papers by Alexander Häge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Häge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Häge. The network helps show where Alexander Häge may publish in the future.

Co-authorship network of co-authors of Alexander Häge

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Häge. A scholar is included among the top collaborators of Alexander Häge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Häge. Alexander Häge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Döpfner, Manfred, Anja Görtz‐Dorten, Alexander Häge, et al.. (2025). Efficacy of a mobile-based self-directed parent management training for parents of children with attention-deficit/hyperactivity disorder with or without oppositional defiant disorder– a randomized controlled trial. European Child & Adolescent Psychiatry. 34(12). 3973–3985.

Kaiser, Anna, et al.. (2025). Performance of large language models ChatGPT and Gemini in child and adolescent psychiatry knowledge assessment. PLoS ONE. 20(9). e0332917–e0332917.

Banaschewski, Tobias, Alexander Häge, Sarah Hohmann, & Konstantin Mechler. (2024). Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use. Frontiers in Psychiatry. 14. 1289157–1289157. 9 indexed citations

Häge, Alexander, et al.. (2024). Emerging therapeutic approaches for Tourette syndrome and other tic disorders – a systematic review of current clinical trials. European Child & Adolescent Psychiatry. 34(6). 1719–1729. 1 indexed citations

Aggensteiner, Pascal-M., Sarah Baumeister, Sarah Hohmann, et al.. (2024). Randomized controlled trial of individualized arousal-biofeedback for children and adolescents with disruptive behavior disorders (DBD). European Child & Adolescent Psychiatry. 33(9). 3055–3066. 4 indexed citations

Dierckx, Bram, et al.. (2023). Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines. European Journal of Pediatrics. 183(3). 1047–1056. 10 indexed citations

Mechler, Konstantin, Regina Dittmann, Tobias Banaschewski, et al.. (2022). Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial. Contemporary Clinical Trials Communications. 29. 100982–100982. 2 indexed citations

Mechler, Konstantin, Jan K. Buitelaar, Sarah Durston, et al.. (2021). “Include me if you can”—reasons for low enrollment of pediatric patients in a psychopharmacological trial. Trials. 22(1). 178–178. 4 indexed citations

Pan, Pei‐Yin, Ulf Jönsson, Alexander Häge, et al.. (2021). Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. Psychological Medicine. 52(1). 14–25. 14 indexed citations

10.

Mechler, Konstantin, Tobias Banaschewski, Sarah Hohmann, & Alexander Häge. (2021). Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics. 230. 107940–107940. 146 indexed citations breakdown →

11.

Mechler, Konstantin, et al.. (2021). Medication Adherence in Adolescents with Psychiatric Disorders. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. 49(4). 295–306. 9 indexed citations

12.

Häge, Alexander, Sarah Hohmann, Sabina Millenet, & Tobias Banaschewski. (2020). Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Kindes- und Jugendalter. Der Nervenarzt. 91(7). 599–603. 4 indexed citations

13.

Mechler, Konstantin, et al.. (2018). Screening for ADHD-Related Symptoms in Preschoolers Should Be Considered—Results From a Representative Sample of 5-Year-Olds From a German Metropolitan Region. Frontiers in Psychiatry. 9. 612–612. 4 indexed citations

14.

Mechler, Konstantin, et al.. (2018). “When I Stop My Medication, Everything Goes Wrong”: Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication. Journal of Child and Adolescent Psychopharmacology. 28(9). 655–662. 8 indexed citations

15.

Mechler, Konstantin, Alexander Häge, Jeffrey Glennon, et al.. (2017). Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie. 46(3). 246–263. 14 indexed citations

16.

Inglis, Sarah K., Sara Carucci, Peter Garas, et al.. (2016). Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. BMJ Open. 6(4). e010433–e010433. 26 indexed citations

17.

Häge, Alexander, Tobias Banaschewski, Jan K. Buitelaar, et al.. (2016). Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial. Trials. 17(1). 141–141. 20 indexed citations

18.

Nagy, Péter, Alexander Häge, David Coghill, et al.. (2015). Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. European Child & Adolescent Psychiatry. 25(2). 141–149. 20 indexed citations

19.

Häge, Alexander, Regina Dittmann, Michael Pennick, et al.. (2014). P.7.f.009 Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD. European Neuropsychopharmacology. 24. S733–S734. 1 indexed citations

20.

Berg, Robert A., et al.. (2012). High Rate of Non-Eligibility: Methodological Factors Impacting on Recruitment for a Multicentre, Double-Blind Study of Paediatric Patients with Major Depressive Disorder. Pharmacopsychiatry. 46(1). 23–28. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact